Catalyst Wire Dossier Catalyst Wire Dossier

Nelarabine

Nelarabine · Alembic Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Nelarabine, covering 2015-01-14 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

See pricing